US Patent 11999783 Method of treating autoimmune disease with antibodies against IL-33
Patent 11999783 was granted and assigned to AnaptysBio on June, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 6 Jun, 2024
Golden AI
Edits made to:
Infobox (+34 properties)
Article (+521 characters)
US Patent 11999783 Method of treating autoimmune disease with antibodies against IL-33
Article
Patent abstract
The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that bind to interleukin-33 (IL-33). The invention provides an IL-33-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. The invention also provides related vectors, compositions, and methods of using the IL-33-binding agent to treat a disorder in a mammal that is responsive to IL-33 inhibition.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Andrew John McKnight0
David J. King0
Robert A. Horlick0
Date of Patent
June 4, 2024
0Patent Application Number
170710460
Date Filed
October 15, 2020
0Patent Citations
0
Patent Primary Examiner
Find more entities like US Patent 11999783 Method of treating autoimmune disease with antibodies against IL-33
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.